Europe Lifts COVID-19 Business Continuity Status

Article

EMA and European regulators are lifting their COVID-19 business continuity measures as the pandemic’s peak ends.

The European Medicines Agency (EMA) announced on May 10, 2023 that it, along with other European regulatory agencies, is ending COVID-19 business continuity measures after the “unprecedented operational challenges posed by the pandemic.” EMA introduced its business continuity plan in 2020 to harness resources for combatting the COVID-19 pandemic. The plan was originally put in place as a response to Brexit and the agency’s relocation from the United Kingdom to the Netherlands.

The continuity plan ensured that EMA, the European Union Member States, and the European Commission could continue to operate while prioritizing COVID-19 actions, such as vaccines and treatment approvals. In addition, activities that were suspended due to the pandemic are gradually being reinstated.

“Throughout the pandemic we proved time and again that public health was our priority and ensured that patients in Europe could continue to have access to the newest, highest-quality therapeutics and vaccines,” said Emer Cooke, EMA’s executive director, in a press release. “Now that the peak of the pandemic has passed, the time is right for EMA and the network to close our business continuity measures. Our approach during the pandemic ensured that we could accelerate the assessment of therapeutics and vaccines for COVID-19 in an unprecedented manner while keeping assessment times for non-COVID products on schedule.”

Source: EMA

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes